Istituto Oncologico Veneto
Padua, Italy
23 recruiting
Showing 1–20 of 23 trials
Recruiting
Phase 3
A Study to Evaluate the Benefit of Adding Durvalumab After Chemotherapy, Durvalumab and Surgery in Patients With Early-stage, Operable, Non-small Cell Lung Cancer.
Non-small Cell Lung Cancer
ETOP IBCSG Partners Foundation290 enrolled42 locationsNCT06284317
Recruiting
Phase 3
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Breast Cancer
Stemline Therapeutics, Inc.4,220 enrolled524 locationsNCT06492616
Recruiting
stereOtactic Body RadIothErapy for exTracranial oligomeTastAtic Breast Cancer: Multi Institutional Retrospective Database
Breast CancerOligometastasis
Istituto Clinico Humanitas300 enrolled28 locationsNCT07397585
Recruiting
Phase 3
Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma
Endometrial Cancer
Karyopharm Therapeutics Inc276 enrolled217 locationsNCT05611931
Recruiting
Observational Study on Endometrial Stromal Tumors
Endometrial Stromal Tumors
Italian Sarcoma Group100 enrolled13 locationsNCT02829437
Recruiting
Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 2021 WHO Classification
Germ Cell TumorGliomaEpendymoma+10 more
European Organisation for Research and Treatment of Cancer - EORTC1,650 enrolled42 locationsNCT05259605
Recruiting
Not Applicable
Silibinin in Association With Concomitant Chemoradiotherapy and Maintenance Temozolomide in STAT3 Positive IDH Wild-type, Newly Diagnosed Glioblastoma Patients
GlioblastomaIDH Wild-type and STAT3-positive Glioblastoma
Istituto Oncologico Veneto IRCCS110 enrolled16 locationsNCT06964815
Recruiting
Novel Therapeutic Approach for Human T-cell Malignancies
T-Cell Leukemia/Lymphoma, Adult
Istituto Oncologico Veneto IRCCS120 enrolled2 locationsNCT06600568
Recruiting
Not Applicable
Preventive Application of Single-use Negative Pressure Wound Therapy (sNPWT) in the Postoperative Course of Radiotreatated Limb Sarcoma Surgery
SarcomaSarcoma,Soft Tissue
Istituto Oncologico Veneto IRCCS48 enrolled1 locationNCT06941194
Recruiting
Phase 3
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Breast Cancer
Greenwich LifeSciences, Inc.750 enrolled161 locationsNCT05232916
Recruiting
Immune Microenvironment and Gene Expression Profiling in Mesothelioma
MesotheliomaMesotheliomas PleuralMesothelioma; Lung
Istituto Oncologico Veneto IRCCS220 enrolled10 locationsNCT06581549
Recruiting
Not Applicable
Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype
Liver CancerMelanomaMerkel Cell Carcinoma+9 more
Istituto Oncologico Veneto IRCCS24 enrolled1 locationNCT06753136
Recruiting
Assessing Financial Toxicity Using the PROFFIT Questionnaire in Patients Treated With Mini-invasive Approach for Urological Malignancies.
Prostate CancerBladder CancerKidney Cancer
Istituto Oncologico Veneto IRCCS120 enrolled1 locationNCT06955910
Recruiting
Changing Paragidms In The Prognostic Assessment Of Hodgkin Lymphoma
Classical Hodgkin LymphomaClassical Hodgkin Lymphoma RecurrentClassical Hodgkin Lymphoma Refractory
Azienda USL Reggio Emilia - IRCCS755 enrolled12 locationsNCT06822855
Recruiting
Phase 3
Gemcitabine Plus Nab-paclitaxel as Switch Maintenance Versus Continuation of Modified FOLFIRINOX as 1st Line Chemotherapy in Patients With Advanced Pancreatic Cancer.
Pancreatic Adenocarcinoma Advanced or Metastatic
Gruppo Oncologico del Nord-Ovest340 enrolled28 locationsNCT06897644
Recruiting
PRostate Cancer Plasma Integrative Multi-modal Evaluation
Metastatic Prostate Cancer
Santa Chiara Hospital800 enrolled4 locationsNCT06981377
Recruiting
Phase 3
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
Metastatic Head and Neck Squamous Cell CarcinomaRecurrent Head and Neck Squamous Cell Carcinoma
AVEO Pharmaceuticals, Inc.410 enrolled110 locationsNCT06064877
Recruiting
Phase 2
Atezolizumab and Rechallenge Chemotherapy in Relapsed Patients With Extensive-stage Small Cell Lung Cancer (ES-SCLC).
Extensive-stage Small Cell Lung Cancer (ES-SCLC)
Gruppo Oncologico Italiano di Ricerca Clinica142 enrolled25 locationsNCT06663098
Recruiting
Phase 3
Atezolizumab Versus Placebo for the Adjuvant Treatment of Malignant Pleural Mesothelioma (Atezomeso)
Mesotheliomas Pleural
Gruppo Oncologico Italiano di Ricerca Clinica162 enrolled19 locationsNCT04996017
Recruiting
Phase 4
Akynzeo as Antiemetic Treatment in Patients With Endometrial Cancer
Endometrial Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano84 enrolled8 locationsNCT06726291